Orion Market Research
GLOBAL CONJUGATE VACCINE MARKET RESEARCH AND FORECAST 2018-2023
CONJUGATE VACCINE
Conjugate vaccines are similar to recombinant vaccines manufactured by the combination of two different components. Conjugate vaccines, however, are made by pieces from the coats of bacteria. These coats are chemically linked to a carrier protein, and the combination is used as a vaccine.
MARKET MOTIVATORS • Rising prevalence of infectious diseases • Increasing regulatory approvals of conjugate vaccines • Government initiatives towards development and awareness of conjugate vaccines • Longer immunity and better safety of conjugate vaccines
MARKET RESTRAINTS
• Complex manufacturing process • Low accessibility in remote areas
MARKET OPPORTUNITIES
• Rising investment in developing countries • Research and development of new vaccines
MARKET SEGMENTATION
BY PRODUCT TYPE • Multivalent conjugate vaccines • Monovalent conjugate vaccines
MARKET SEGMENTATION
BY DISEASE •Meningococcal, •Diphtheria tetanus pertussis, •Influenza, •Pneumococcal, •Others.
MARKET SEGMENTATION
BY PATIENT TYPE •Adults •Children
MARKET SEGMENTATION
BY PATHOGEN TYPE •Bacterial conjugate vaccine •Viral conjugate vaccine •Combination vaccine
REGIONAL ANALYSIS
COMPANY PROFILE
• • • • • • •
Astellas pharma Astrazeneca Bharat biotech Biological e ltd. Csl behring Glaxosmithkline plc. Mitsubishi tanabe pharma
To be continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE
Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com
https://www.omrglobal.com/industry-reports/conjugate-vaccine-market/